Home
>
National Drug Code (NDC)
>
Zetia
Zetia - 66582-414-15 - (Ezetimibe)
Drug Information of Zetia
| Product NDC: | 66582-414 |
| Proprietary Name: | Zetia |
| Non Proprietary Name: | Ezetimibe |
| Active Ingredient(s): | 10 mg/1 & nbsp; Ezetimibe |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zetia
| Product NDC: | 66582-414 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021445 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20021025 |
Package Information of Zetia
| Package NDC: | 66582-414-15 |
| Package Description: | 7 TABLET in 1 BLISTER PACK (66582-414-15) |
NDC Information of Zetia
| NDC Code | 66582-414-15 |
| Proprietary Name | Zetia |
| Package Description | 7 TABLET in 1 BLISTER PACK (66582-414-15) |
| Product NDC | 66582-414 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ezetimibe |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20021025 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | EZETIMIBE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC] |
